NCT04118998

Brief Summary

This study attempts to minimize the development of a common movement impairment following stroke known as "flexion synergy" that makes it extremely difficult to reach outward with the arm. Participants with acute/subacute stroke will receive one of two study interventions in addition to prescribed therapies in both inpatient rehabilitation and day-rehab. Participants will be followed for 1 year.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Aug 2021Aug 2026

First Submitted

Initial submission to the registry

September 23, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 8, 2019

Completed
1.9 years until next milestone

Study Start

First participant enrolled

August 27, 2021

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

October 8, 2025

Status Verified

October 1, 2025

Enrollment Period

5 years

First QC Date

September 23, 2019

Last Update Submit

October 3, 2025

Conditions

Keywords

RehabilitationArmFlexion SynergyLongitudinalTargettedQuantitative

Outcome Measures

Primary Outcomes (1)

  • Change in Reaching Function

    Quantitative evaluation of reaching by calculating distance from reaching kinematics data during ballistic outward reaches against gravity.

    Change in Reaching function will be modeled from baseline, weekly (until discharge from rehabilitation, on average 4 to 10 weeks), and monthly evaluations (every-other month until 12 months post-stroke).

Secondary Outcomes (4)

  • Change in Loss of Independent Joint Control

    Change in Loss of Independent Joint Control will be modeled from baseline, weekly (until discharge from rehabilitation, on average 4 to 10 weeks), and monthly evaluations (every-other month until 12 months post-stroke).

  • Change in Fugl-Meyer Motor Assessment

    Change in Fugl-Meyer Motor Assessment will be modeled from baseline, weekly (until discharge from rehabilitation, on average 4 to 10 weeks), and monthly evaluations (every-other month until 12 months post-stroke).

  • Change in Action Research Arm Test

    Change in Action Research Arm Test will be modeled from baseline, weekly (until discharge from rehabilitation, on average 4 to 10 weeks), and monthly evaluations (every-other month until 12 months post-stroke).

  • Change in Stroke Impact Scale

    Change in Stroke Impact Scale will be modeled from baseline, weekly (until discharge from rehabilitation, on average 4 to 10 weeks), and monthly evaluations (every-other month until 12 months post-stroke).

Study Arms (2)

Abduction Loading

EXPERIMENTAL

The intervention for the experimental group entails practicing reaching with abduction loading.

Behavioral: Abduction Loading

Supported Reaching

ACTIVE COMPARATOR

The intervention for the active comparator entails practicing reaching while supported.

Behavioral: Supported Reaching

Interventions

The intervention for the experimental group entails practicing reaching with abduction loading.

Also known as: Progressive Abduction Loading Therapy
Abduction Loading

The intervention for the active comparator entails practicing reaching while supported.

Supported Reaching

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemiparesis confined to one side, (CMSA Stage 2 or 3 out of 7)
  • Stroke impacting parenchyma of the middle cerebral artery distribution
  • Within 90 days post-stroke
  • to 85 years old
  • No or Mild-to-moderate Aphasia (NIHSS #9 Best Language. = 0 or 1- Describe picture; No or Mild-to-moderate Aphasia)
  • No or Mild extinction and inattention (NIHSS 11 Extinction and Inattention. = 0 or 1- No abnormality or Inattention to one modality.)
  • Ability to perform a 3-step motor command with the unaffected arm
  • Capacity to provide informed consent

You may not qualify if:

  • Premorbid and persistent disability or motor impairment of the upper extremities
  • Brainstem and/or cerebellar lesion
  • Comorbidity medically contraindicating motor assessments
  • Any other chronic neurological condition
  • Pain or hypersensitivity limiting motor assessments
  • Limb edema limiting study motor assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Department of Physical Therapy and Human Movement Sciences

Chicago, Illinois, 60611, United States

Location

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

Location

Northwestern Medicine Marianjoy Rehabilitation Hospital

Wheaton, Illinois, 60187, United States

Location

Related Publications (4)

  • Yamada K. The glossophyaryngeal nerve response to taste and thermal stimuli in the rat, rabbit and cat. Kumamoto Med J. 1965 Jun 30;18(2):106-8. No abstract available.

    PMID: 5825888BACKGROUND
  • Martig J, Riser WH, Germann F. Deforming ankylosis of the coffin joint in calves. Vet Rec. 1972 Sep 23;91(13):307-10. doi: 10.1136/vr.91.13.307. No abstract available.

    PMID: 5086410BACKGROUND
  • Chou MY, Malison MD. Outbreak of acute hemorrhagic conjunctivitis due to coxsackie A24 variant--Taiwan. Am J Epidemiol. 1988 Apr;127(4):795-800. doi: 10.1093/oxfordjournals.aje.a114861.

    PMID: 2833097BACKGROUND
  • Roth HR, Carmona C, Clark G, Gyarmaty JE, Dewald JPA, Giblin E, Harvey RL, Jaskiewicz J, Kim KA, Lancki N, Luhrsen A, Mandana A, Manikonda D, Morris A, Sheth S, Stoykov ME, Young AC, Zielke D, Ellis MD. PRALINE: study protocol for a phase IIb inpatient stroke rehabilitation randomized controlled trial investigating longitudinal outcomes after progressive abduction loading therapy. Trials. 2025 Jul 20;26(1):250. doi: 10.1186/s13063-025-08969-6.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Michael D Ellis, PT, DPT

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The two arms or study interventions are indistinguishable by patients and untrained observers. The Care Providers (Study Intervention Therapists) can not be masked due to their knowledge in the delivery of the physical intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 23, 2019

First Posted

October 8, 2019

Study Start

August 27, 2021

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

October 8, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Final research data will be shared openly and timely in accordance with NIH Data Sharing Policy (https://grants.nih.gov/grants/policy/data\_sharing/) and NICHD Data and Specimen Hub - Data Archive Policy Statement (https://dash.nichd.nih.gov/Resource/Policies). Data sharing will occur through the primary repositories of NICHD DASH (https://dash.nichd.nih.gov/), Northwestern University DigitalHub (https://digitalhub.northwestern.edu/), and Open Science Framework (https://osf.io/). Data will be exported from the internal RedCap study data base in spreadsheet format and will be deidentified and coded. Data will be available through speaking engagements and publications, presentations at scientific symposia and seminars. Data sharing in the above repositories will be phased in time with acceptance for publication of the primary outcome paper near the end of the fifth year and then with each subsequent publication. Publications will include DOIs for the data repositories.

Time Frame
Data sharing in the above repositories will be phased in time with acceptance for publication of the primary outcome paper near the end of the fifth year and then with each subsequent publication.
Access Criteria
Data sharing will occur through the primary repositories of NICHD DASH (https://dash.nichd.nih.gov/), Northwestern University DigitalHub (https://digitalhub.northwestern.edu/), and Open Science Framework (https://osf.io/). Data will be exported from the internal RedCap study data base in spreadsheet format and will be deidentified and coded. Data will be available through speaking engagements and publications, presentations at scientific symposia and seminars.
More information

Locations